Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Graft-Versus-Host Disease

1-methyl-3-isobutylxanthine has been researched along with Graft-Versus-Host Disease in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Shaughnessy, MJ1
Chen, ZM1
Gramaglia, I1
Taylor, PA1
Panoskaltsis-Mortari, A1
Vogtenhuber, C1
Palmer, E1
Grader-Beck, T1
Boussiotis, VA1
Blazar, BR1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Graft-Versus-Host Disease

ArticleYear
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Animals; CD4-Positive T-Lymphocytes; Cell Transplantation; Cyclic AMP;

2007